IMMUNOHISTOCHEMISTRY, HER-2 / ERBB2

Her-2 is an important marker for therapeutic purpose in breast carcinoma.

  • Test Type:
  • Pre-test Information:
    Provide a copy of the Histopathology / Cytopathology report & give brief clinical history.
  • Report Delivery:
    Sample daily by 6 pm Report Blocks : 5 Days Tissues : 7 Days
  • Components:
    0

Sample Report